For instance, in direct (in vivo) gene therapy, adenoviruses carrying the p53 gene are used for the treatment of head and neck squamous cell carcinoma, while adeno-associated viruses delivering the SMN1 gene are employed to treat spinal muscular atrophy (SMA) [15,16]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.